Orloff John J Insider Trades

Insider Trading History

Track insider trading activity for Orloff John J. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Zenas BioPharma
Zenas BioPharma ZBIO
Director
Holding Value $340k 18,500 shares
Last Trade
Jun 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$221k 18,500 shares
$11.94
$18.38
Alexion Pharmaceuticals
Alexion Pharmaceuticals ALXN
Evp, Research & Development
Holding Value $0 0 shares
Last Trade
Jul 21, 2021 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$26.7M 146,511 shares
$182.50
$182.50
Alexion Pharmaceuticals
Alexion Pharmaceuticals ALXN
Evp, Research & Development
Holding Value $15.8M 86,367 shares
Last Trade
Jun 08, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$346k 1,957 shares
$177.00
$182.50
Alexion Pharmaceuticals
Alexion Pharmaceuticals ALXN
Evp, Research & Development
Holding Value $16.1M 88,324 shares
Last Trade
Feb 28, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.74M 24,473 shares
$152.75
$182.50
Alexion Pharmaceuticals
Alexion Pharmaceuticals ALXN
Evp, Research & Development
Holding Value $11.6M 63,811 shares
Last Trade
Dec 16, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$3.38M 21,395 shares
$157.96
$182.50
Alexion Pharmaceuticals
Alexion Pharmaceuticals ALXN
Evp, Research & Development
Holding Value $15.6M 85,206 shares
Last Trade
Dec 16, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.43M 40,677 shares
$158.03
$182.50
Alexion Pharmaceuticals
Alexion Pharmaceuticals ALXN
Evp, Research & Development
Holding Value $11.7M 63,851 shares
Last Trade
Dec 15, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.32k 40 shares
$157.91
$182.50
Alexion Pharmaceuticals
Alexion Pharmaceuticals ALXN
Evp, Research & Development
Holding Value $8.13M 44,529 shares
Last Trade
Jun 08, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$319k 2,784 shares
$114.61
$182.50
Alexion Pharmaceuticals
Alexion Pharmaceuticals ALXN
Evp, Research & Development
Holding Value $8.63M 47,275 shares
Last Trade
Mar 02, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$126k 1,396 shares
$90.54
$182.50
Alexion Pharmaceuticals
Alexion Pharmaceuticals ALXN
Evp, Research & Development
Holding Value $8.88M 48,671 shares
Last Trade
Feb 28, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.02M 10,880 shares
$94.03
$182.50
Alexion Pharmaceuticals
Alexion Pharmaceuticals ALXN
Evp, Research & Development
Holding Value $8.63M 47,313 shares
Last Trade
Dec 15, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.2k 38 shares
$110.42
$182.50
Alexion Pharmaceuticals
Alexion Pharmaceuticals ALXN
Evp, Research & Development
Holding Value $6.9M 37,791 shares
Last Trade
Jun 07, 2019 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$330k 2,786 shares
$118.61
$182.50
Alexion Pharmaceuticals
Alexion Pharmaceuticals ALXN
Evp, Research & Development
Holding Value $7.41M 40,577 shares
Last Trade
Feb 28, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.28M 9,428 shares
$135.33
$182.50
Alexion Pharmaceuticals
Alexion Pharmaceuticals ALXN
Evp, Research & Development
Holding Value $5.68M 31,115 shares
Last Trade
Feb 28, 2019 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$89.7k 675 shares
$132.92
$182.50
Alexion Pharmaceuticals
Alexion Pharmaceuticals ALXN
Evp, Research & Development
Holding Value $5.68M 31,149 shares
Last Trade
Dec 15, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.72k 34 shares
$109.43
$182.50
Alexion Pharmaceuticals
Alexion Pharmaceuticals ALXN
Evp, Research & Development
Holding Value $5.8M 31,790 shares
Last Trade
Jun 08, 2018 Sale (Open Market)Shares sold on the open market or in a private sale.
$251k 2,115 shares
$118.53
$182.50
Alexion Pharmaceuticals
Alexion Pharmaceuticals ALXN
Evp, Research & Development
Holding Value $6.19M 33,905 shares
Last Trade
Feb 28, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.05M 8,940 shares
$117.45
$182.50
Alexion Pharmaceuticals
Alexion Pharmaceuticals ALXN
Evp, Research & Development
Holding Value $4.56M 24,965 shares
Last Trade
Jun 07, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.5M 24,965 shares
$100.14
$182.50

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up